| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/2008 | CN101270359A Method for preparing recombined human amyloid A beta 42 and application thereof |
| 09/24/2008 | CN101270160A Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody |
| 09/24/2008 | CN101270158A Target glioma resistant protein, preparation method and application |
| 09/24/2008 | CN101270157A Genetic engineering target glioma Acp-W1 resistant protein, preparation method and application |
| 09/24/2008 | CN101270154A Cyclo-pentapeptide with antineoplastic activity |
| 09/24/2008 | CN101270152A Peptide medicament series for accelerating medulla hematopoiesis cell proliferation |
| 09/24/2008 | CN101270151A Peptide medicaments for accelerating medulla hematopoiesis cell proliferation |
| 09/24/2008 | CN101270150A Truncate soluble human vascellum endothelial cell growth factor acceptor, prepraring method and uses thereof |
| 09/24/2008 | CN101270147A Achyranthes bidentata polypeptide, preparing process and uses |
| 09/24/2008 | CN101270145A Preparation technique for GHGKHKNK octapeptide and medicine use |
| 09/24/2008 | CN101269217A Compound digestive enzyme locating release capsule |
| 09/24/2008 | CN101269216A Oral preparation for reducing brinolase, preparation method and uses thereof |
| 09/24/2008 | CN101269215A Glucoprotein incretion composition |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/24/2008 | CN101269213A Soluble preparation of bone morphogenesis protein-7 and application thereof |
| 09/24/2008 | CN101269212A Gargle capable of being swallowed |
| 09/24/2008 | CN101269211A Shuangtang high calcium medicinal granule and preparation technique |
| 09/24/2008 | CN101269210A Ketogenic mix preparation suitable for treating intractable epilepsy |
| 09/24/2008 | CN100420743C Probiotic composite enzyme production method |
| 09/24/2008 | CN100420485C Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof |
| 09/24/2008 | CN100420484C Human lysozyme suppository, preparation method and application |
| 09/24/2008 | CN100420483C Sigma ligands for neuronal regeneration and functional recovery |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/23/2008 | US7427678 Reacting a derivatized molecule with a support; diels-alder reaction; fluorescein; diene or dienophile |
| 09/23/2008 | US7427671 DNA sequence which code human platelet derived growth factor receptor proteins which preferentially binds to dimers of platelet derived growth factors with high receptivity |
| 09/23/2008 | US7427669 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427661 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427657 Aromatic sulfenates for type 1 phototherapy |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427611 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder |
| 09/23/2008 | US7427603 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 09/23/2008 | US7427602 nucleic acid-matrix materials are created such that they maintain a defined space, allowing cellular migration, transfection and proliferation to occur in a controlled manner; in vivo cell transfection and gene expression |
| 09/23/2008 | US7427601 Method for treating tremor |
| 09/23/2008 | US7427600 mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage |
| 09/23/2008 | US7427599 stimulating T-cell transformation; cell proliferative disorder, anti-cancer, and/or anti-sarcoma |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427597 Method of treating brain tissue damages |
| 09/23/2008 | US7427596 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 09/23/2008 | US7427595 Use of proepithelin to promote wound repair and reduce inflammation |
| 09/23/2008 | US7427594 Methods and pharmaceuticals compositions for treating coronary artery disease, ischemia,and vascular disease using angiopoietins |
| 09/23/2008 | US7427593 Methods of making triacylglycerol using phospholipid:Diacylglycerol acyltransferase |
| 09/23/2008 | US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427590 Neurothrophic components of the ADNF I complex |
| 09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427496 To inhibit tumor growth in an animal; to induce apoptosis |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427488 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/23/2008 | US7427486 Mullerian inhibiting substance levels and ovarian response |
| 09/23/2008 | US7427482 screening for nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents |
| 09/23/2008 | US7427478 Beta-secretase enzyme compositions and methods |
| 09/23/2008 | US7427470 Antisense modulation of helicase-moi expression |
| 09/23/2008 | US7427410 Coating hydrophobic surfaces with amphiphilic thioethers to reduce protein adsorption and cell adhesion |
| 09/23/2008 | US7427408 Therapy, prevention of microorganism infection; contacting surfaces; signal passageway |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2437820C Endomural therapy |
| 09/23/2008 | CA2372992C Selenium-containing pro-drugs for cancer therapy |
| 09/23/2008 | CA2333323C Method and compositions for treatment of cancers |
| 09/23/2008 | CA2332126C A novel human thrombopoietin mutein |
| 09/23/2008 | CA2259940C High-affinity interleukin-4 muteins |
| 09/23/2008 | CA2206008C Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 09/23/2008 | CA2192773C Production of sustained-release preparation for injection |
| 09/23/2008 | CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy |
| 09/23/2008 | CA2157047C Aureobasidins |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/23/2008 | CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 09/23/2008 | CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1 |
| 09/18/2008 | WO2008113030A2 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 09/18/2008 | WO2008112987A1 Treating skin cancer |
| 09/18/2008 | WO2008112941A1 Composition and method for the treatment of diseases affected by a peptide receptor |
| 09/18/2008 | WO2008112939A2 Composition and method for making oligo-benzamide compounds |
| 09/18/2008 | WO2008112938A2 Composition and method for the treatment of diseases affected by a peptide receptor |
| 09/18/2008 | WO2008112887A1 Methods of treating juvenile type 1 diabetes mellitus |
| 09/18/2008 | WO2008112840A2 Novel composition and methods for the treatment of immune related diseases |
| 09/18/2008 | WO2008112836A2 Pharmaceutical composition comprising human growth hormon |
| 09/18/2008 | WO2008112807A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing |
| 09/18/2008 | WO2008112772A2 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | WO2008112736A1 Tighter-binding c-peptide inhibitors of hiv-1 entry |
| 09/18/2008 | WO2008112559A1 Suppression of galectin-3 for treating an inflammatory condition |
| 09/18/2008 | WO2008112368A2 Phenylalkylcarboxylic acid delivery agents |
| 09/18/2008 | WO2008112325A2 Treatment of autoimmune disorders |
| 09/18/2008 | WO2008112320A1 Inhibition of ion channel function |
| 09/18/2008 | WO2008112018A2 Apparatus and method for treating obesity using neurotoxins in conjuction with bariatric procedures |
| 09/18/2008 | WO2008111996A2 Muc1-ikb kinase complexes and their activities |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111573A1 Growth hormone secretion stimulator |
| 09/18/2008 | WO2008111562A1 Whitening agent |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111503A1 Protective agent for transplanted organ |
| 09/18/2008 | WO2008111441A1 Pharmaceutical composition |
| 09/18/2008 | WO2008111271A1 Oral composition for nourishing the hair and stimulating hair growth |
| 09/18/2008 | WO2008110777A2 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 09/18/2008 | WO2008110771A2 Composition comprising an il-8 blocking agent and/or a trail blocking agent for use in the treatment of liver disease and hepatic flares |